Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)

NCT01884571 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

DRUG: Basiliximab
DRUG: Methylprednisolone
DRUG: Prednisone
DRUG: Tacrolimus
DRUG: Mycophenolate mofetil

Sponsor

Emory University

Collaborators

[object Object]